Literature DB >> 19879978

Etiopathogenesis of Behcet's disease.

Claudia Mendoza-Pinto1, Mario García-Carrasco, Mario Jiménez-Hernández, Cesar Jiménez Hernández, Carlos Riebeling-Navarro, Arnulfo Nava Zavala, Mauricio Vera Recabarren, Gerard Espinosa, Javier Jara Quezada, Ricard Cervera.   

Abstract

Bechet's disease (BD) is an inflammatory, multi systemic disease with spontaneous remissions and relapses similar to various autoimmune diseases. BD leads to organ damage, including the eyes, skin, joints, etc., which produces various clinical manifestations. The central histopathologic characteristic is systemic vasculitis with perivascular inflammatory infiltrates. The etiopathogenesis is unknown, although immunological abnormalities, possibly induced by susceptible microbiological pathogens, have been postulated. Copyright 2009. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879978     DOI: 10.1016/j.autrev.2009.10.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  45 in total

1.  Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms.

Authors:  Hyun-Mee Oh; Cheng-Rong Yu; Yongjun Lee; Chi-Chao Chan; Arvydas Maminishkis; Charles E Egwuagu
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

2.  Association between the ACE gene I/D polymorphism and osteoporosis in a Turkish population.

Authors:  B Cakmak; A Inanir; N Karakus; O Ates; S Yigit
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

Review 3.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Association of Rho-kinase 1 (ROCK1) gene polymorphisms with Behçet's disease.

Authors:  Elif Oguz; Abdullah Tuncay Demiryürek; Yavuz Pehlivan; Bünyamin Kisacik; Esma Ozkara; Serdar Oztuzcu; Belgin Alasehirli; Ahmet Mesut Onat
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

5.  High Levels of Circulating Endothelial Progenitor Cells Are Associated with Acrotism in Patients with Takayasu Arteritis.

Authors:  Şakir Özgür Keşkek; Emine Duygu Bozkırlı-Ersözlü; Ilknur Kozanoglu; Ahmet Eftal Yücel
Journal:  Med Princ Pract       Date:  2016-11-03       Impact factor: 1.927

6.  Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?

Authors:  Marwa Hammad; Omaima Zakaria Shehata; Shaimaa Mohamed Abdel-Latif; Amany Mohamed Mohiey El-Din
Journal:  Clin Rheumatol       Date:  2018-07-07       Impact factor: 2.980

7.  New approaches in immunotherapy of behçet disease.

Authors:  Fatemeh Zare Shahneh; Mozhdeh Mohammadian; Zohreh Babaloo; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-02-07

8.  High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.

Authors:  Charles F Henderson; Robert A Brodsky; Richard J Jones; Stuart M Levine
Journal:  Semin Arthritis Rheum       Date:  2011-02-03       Impact factor: 5.532

9.  DD genotype of ACE gene I/D polymorphism is associated with Behcet disease in a Turkish population.

Authors:  Serbülent Yigit; Sengül Tural; Aydin Rüstemoglu; Ahmet Inanir; Ulker Gul; Goknur Kalkan; Songul Akkanet; Nevin Karakuş; Omer Ateş
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

10.  Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.

Authors:  Mehmet Balbaba; Fatih Ulaş; Hakan Yıldırım; Adem Soydan; Ali Dal; Süleyman Aydın
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.